Regional Meetings, January – May 2012

Survey Says: An Interactive Grand Rounds Series Focused on Real Cases of Patients with Non-Small Cell Lung Cancer

Research To Practice (RTP) is pleased to offer practicing oncologists and other allied healthcare professionals throughout the United States the opportunity to attend a live pilot educational activity focused on the management of non-small cell lung cancer (NSCLC). The activity will include a blend of didactic minipresentations (using real cases as an educational framework), interactive polling of the audience utilizing personal mobile phones and follow-up discussion/audience Q&A.

Dates and Times
Faculty and Locations
 

Friday, January 6, 2012
12:00 PM – 1:00 PM EST
(Lunch will be provided)Registration is open only to oncology
professionals from this institution Email Us for More Information »

Faculty: Lecia V Sequist, MD, MPH

Location: Norwalk Hospital
Whittingham Cancer Center
Maple Street
Norwalk, CT 06856

Richard S Perkin Auditorium
 

Wednesday, February 15, 2012
12:00 PM – 1:00 PM CT
(Lunch will be provided)Registration is open only to oncology
professionals from this institution Email Us for More Information »

Faculty: Heather Wakelee, MD

Location: University of Nebraska Medical Center
Lied Transplant Center, 8th floor
4301 Emile St
Omaha, NE 68105

Meeting Room: LTC 8707-08
 

Monday, February 20, 2012
5:30 PM – 6:30 PM CT
(Dinner will be provided) Registration is also open to medical
oncologists outside of this institution Register Here »

Faculty: Edward S Kim, MD

Location: Texas Oncology-Austin Midtown
901 W 38th Street
Austin, TX 78705

Board Room, 3rd Floor
 

Friday, March 23, 2012
3:00 PM – 4:00 PM EST
(Snack will be provided)Registration for oncology professionals
outside of this institution is limited. Email Us for More Information »

Faculty: Heather Wakelee, MD

Location: Illinois CancerCare
8940 N Wood Sage Road
Peoria, IL 61615

Meeting Room TBC
 

Tuesday, March 27, 2012
12:00 PM – 1:00 PM EST
(Lunch will be provided)Registration is open only to oncology
professionals from this institution Email Us for More Information »

Faculty: Mark A Socinski, MD

Location: Ocala Regional Medical Center
1431 SW First Avenue
Ocala, FL 34474

Meeting Room TBC
 

Wednesday, March 28, 2012
1:00 PM – 2:15 PM EST
(Lunch will be provided) Registration is also open to medical
oncologists outside of this institution Register Here »

Faculty: Mark A Socinski, MD

Location: Maimonides Cancer Center
6300 Eighth Avenue
Brooklyn, NY 11220

1st Floor Cancer Center Conference Room
 

Thursday, March 29, 2012
6:30 PM – 8:00 PM EST
(Dinner will be provided) Registration is also open to medical
oncologists from other Florida Cancer Specialists locations Email Us for More Information »

Faculty: Edward S Kim, MD

Location for Florida Cancer Specialists Group: Stillwater Grille
13451 McGregor Boulevard
Fort Myers, FL 33919
 

Wednesday, April 11, 2012
8:00 AM – 9:00 AM EST
(Breakfast will be provided)Registration is also open to medical
oncologists outside of this institutionRegister Here »

Faculty: Corey J Langer, MD

Location: Aultman Cancer Center
2600 Sixth Street SW
Canton, OH 44710

Education Amphitheatre
 

Wednesday, April 18, 2012
12:30 PM – 1:30 PM EST
(Lunch will be provided)Registration is open only to oncology
professionals from this institutionEmail Us for More Information »

Faculty: Corey J Langer, MD

Location: Inova Fairfax Hospital
3300 Gallows Road
Falls Church, VA 22042

Conference Room DEF
 

Wednesday, May 9, 2012
12:00 PM – 1:00 PM
(Lunch will be provided)Registration is open only to oncology
professionals from this institutionEmail Us for More Information »

Faculty: Lecia V Sequist, MD, MPH

Location: Orlando Health
1400 S Orange Ave, MP 705
Orlando, Florida 32806

Conference Room TBD
 

There is no registration fee for these events. However, preregistration is advised, as seating is limited.

Each of the 1-hour sessions will include 4 topic modules focused on a number of important issues in the management of NSCLC. Each module will employ an identical format and include:
  • Related Faculty Case Presentation
  • Audience Polling Using Text Messaging
  • Display of Steering Committee Members' Treatment Recommendations
  • Faculty Review of Select Data Sets
Module 1: EGFR mutation and ALK translocation testing and treatment implications Module 2: Treatment of EGFR and ALK wild-type metastatic NSCLC Module 3: Metastatic squamous cell NSCLC Module 4: Adjuvant systemic therapy Each session will conclude with a 10-minute Q&A segment

STEERING COMMITTEE MEMBERS AND PARTICIPATING FACULTY

Chandra P Belani, MD
Miriam Beckner Distinguished
Professor of Medicine
Penn State College of Medicine
Deputy Director
Penn State Hershey Cancer Institute
Hershey, Pennsylvania

Edward S Kim, MD
Associate Professor of Medicine
Chief, Section of Head and
Neck Medical Oncology
Director, Clinical Research Operations
Department of Thoracic/Head and Neck
Medical Oncology
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Corey J Langer, MD
Director of Thoracic Oncology
Abramson Cancer Center
Professor of Medicine
University of Pennsylvania
Vice Chair, Radiation Therapy
Oncology Group
Philadelphia, Pennsylvania

Alan B Sandler, MD
Professor of Medicine
Division Chief, Hematology and Medical Oncology
DeArmond Chair for Clinical Cancer Research
Co-Director, Clinical Management Research
Associate Director for Clinical Research
Knight Cancer Institute
Oregon Health and Science University
Portland, Oregon
Lecia V Sequist, MD, MPH
Assistant Professor of Medicine
Harvard Medical School
Center for Thoracic Cancers
Massachusetts General Hospital
Cancer Center
Boston, Massachusetts

Mark A Socinski, MD
Professor of Medicine and Thoracic Surgery
Director, Lung Cancer Section
Division of Hematology/Oncology
Co-Director, UPMC Lung Cancer
Center of Excellence
Co-Director, Lung and Thoracic
Malignancies Program
University of Pittsburgh
UPMC Cancer Pavilion
Pittsburgh, Pennsylvania

Heather Wakelee, MD
Assistant Professor of Medicine
Division of Oncology
Stanford University School of Medicine
Stanford Cancer Institute
Stanford, California

Project Chair

Neil Love, MD
Research To Practice
Miami, Florida
 

Target Audience:
This activity is intended for medical, surgical and radiation oncologists, thoracic surgeons and other allied professionals involved in the treatment of NSCLC.

Learning Objectives and Goals:

  • Counsel patients with localized NSCLC about the risk-adjusted, long-term clinical effects of adjuvant chemotherapy.
  • Use biomarkers, clinical characteristics and tumor histology to select individualized front-line and subsequent treatment approaches for patients with metastatic NSCLC.
  • Identify patients with metastatic NSCLC who may experience clinical benefit from the addition of maintenance biologic therapy and/or chemotherapy.
  • Recognize the effect of NSCLC tumor-specific mutations on relative response or resistance to treatment with EGFR tyrosine kinase inhibitors, monoclonal antibodies and other emerging molecular-targeted agents.
  • Counsel appropriately selected patients about the availability of ongoing clinical trial participation.
  • Employ case-based learning to refine or validate your existing NSCLC treatment algorithms.

CME Credit Form:
A CME credit form will be given to each participant at the conclusion of the activity.

Accreditation Statement:
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement:
Research To Practice designates each live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy:
As a provider accredited by the Accreditation Council for Continuing Medical Education, it is the policy of Research To Practice to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. Financial disclosures and disclosures of discussions of unlabeled/unapproved uses of drugs or devices will be provided in meeting course materials.

Supporters:
These events are supported by educational grants from Astellas, Genentech BioOncology and Lilly USA LLC.